Boston Scientific stock flat after Nalu buy closes; BSX investors eye Feb. 4 earnings
Boston Scientific shares were flat Tuesday afternoon after confirming the $600 million acquisition of Nalu Medical. The deal adds a peripheral nerve stimulation system to its pain-management lineup. Investors await the company’s Feb. 4 earnings release for 2026 guidance. BSX traded at $93.54, down 0.01% by 2:43 p.m. ET.